|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 2/27/24 ICU Medical, Inc. 10-K 12/31/23 150:15M |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.81M
2: EX-10.3 Material Contract HTML 41K
3: EX-10.4 Material Contract HTML 38K
4: EX-21 Subsidiaries List HTML 51K
5: EX-23.1 Consent of Expert or Counsel HTML 39K
9: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 58K
Awarded Compensation
6: EX-31.1 Certification -- §302 - SOA'02 HTML 43K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 43K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 42K
15: R1 Document and Entity Information Document HTML 105K
16: R2 Audit Information HTML 44K
17: R3 Consolidated Balance Sheets HTML 169K
18: R4 Consolidated Statements of Income HTML 117K
19: R5 Statement of Comprehensive Income (Statement) HTML 66K
20: R6 Consolidated Statements of Stockholders Equity HTML 100K
21: R7 Consolidated Statements of Cash Flows HTML 181K
22: R8 Consolidated Balance Sheets (Parenthetical) HTML 61K
23: R9 Statement of Comprehensive Income (Paranthetical) HTML 47K
24: R10 General and Summary of Significant Accounting HTML 233K
Policies
25: R11 Acquisitions (Notes) HTML 75K
26: R12 Restructuring, Strategic Transaction and HTML 69K
Integration (Notes)
27: R13 Revenue (Notes) HTML 106K
28: R14 Leases (Notes) HTML 98K
29: R15 Share Based Award Share awards (Notes) HTML 143K
30: R16 Derivatives and Hedging Activities (Notes) HTML 106K
31: R17 Fair Value Measurement (Notes) HTML 143K
32: R18 Prepaids and Other Current Assets (Notes) HTML 64K
33: R19 Accrued Liabilities an Other Long-term Liabilities HTML 81K
34: R20 Debt HTML 97K
35: R21 Income Taxes HTML 169K
36: R22 Geographic Information and Significant Customers HTML 58K
Geographic Information and Significant Customers
(Notes)
37: R23 Stockholders' Equity HTML 79K
38: R24 Commitments and Contingencies HTML 48K
39: R25 Collaborative and Other Arrangements (Notes) HTML 44K
40: R26 Transfers and Servicing HTML 49K
41: R27 SEC Schedule, Article 12-09, Valuation and HTML 90K
Qualifying Accounts
42: R28 Pay vs Performance Disclosure HTML 51K
43: R29 Insider Trading Arrangements HTML 49K
44: R30 General and Summary of Significant Accounting HTML 124K
Policies (Policies)
45: R31 General and Summary of Significant Accounting HTML 214K
Policies (Tables)
46: R32 Business Combination and Asset Acquisition HTML 68K
(Tables)
47: R33 Restructuring, Strategic Transaction and HTML 65K
Integration Schedule of Restructuring and Related
Costs (Tables)
48: R34 Revenue (Tables) HTML 99K
49: R35 Leases (Tables) HTML 102K
50: R36 Share Based Award (Tables) HTML 131K
51: R37 Derivatives and Hedging Activities (Tables) HTML 99K
52: R38 Fair Value Measurement (Tables) HTML 127K
53: R39 Prepaids and Other Current Assets (Tables) HTML 66K
54: R40 Accrued Liabilities an Other Long-term Liabilities HTML 82K
(Tables)
55: R41 Debt (Tables) HTML 86K
56: R42 Income Taxes Income tax disclosure (Tables) HTML 170K
57: R43 Geographic Information and Significant Customers HTML 58K
Geographic Information (Tables)
58: R44 Stockholders' Equity (Tables) HTML 72K
59: R45 General and Summary of Significant Accounting HTML 41K
Policies Basis of Presentation (Details)
60: R46 General and Summary of Significant Accounting HTML 47K
Policies Inventory (Details)
61: R47 General and Summary of Significant Accounting HTML 63K
Policies Property and Equipment #1 (Details)
62: R48 General and Summary of Significant Accounting HTML 61K
Policies Property and Equipment #2 (Details)
63: R49 General and Summary of Significant Accounting HTML 41K
Policies Property and Equipment #3 (Details)
64: R50 General and Summary of Significant Accounting HTML 54K
Policies Goodwill (Details)
65: R51 General and Summary of Significant Accounting HTML 77K
Policies Intangible Assets #1 (Details)
66: R52 General and Summary of Significant Accounting HTML 41K
Policies Intangible Assets #2 (Details)
67: R53 General and Summary of Significant Accounting HTML 55K
Policies Future Estimated Amortization Expense
(Details)
68: R54 General and Summary of Significant Accounting HTML 72K
Policies Investments (Details)
69: R55 General and Summary of Significant Accounting HTML 50K
Policies Investments-Equity Method (Details)
70: R56 General and Summary of Significant Accounting HTML 42K
Policies Income Taxes
71: R57 General and Summary of Significant Accounting HTML 42K
Policies Foreign Currency (Details)
72: R58 General and Summary of Significant Accounting HTML 40K
Policies Post-retirement and Post-employment
Benefits (Details)
73: R59 General and Summary of Significant Accounting HTML 46K
Policies Interest (Expense) Income, net (Details)
74: R60 General and Summary of Significant Accounting HTML 55K
Policies Other (Expense) Income, Net (Details)
75: R61 General and Summary of Significant Accounting HTML 73K
Policies Net Income Per Share (Details)
76: R62 General and Summary of Significant Accounting HTML 56K
Policies New Accounting Pronouncements (Details)
77: R63 Acquisitions Text (Details) HTML 62K
78: R64 Acquisitions Smiths Medical 2020 Limited Table HTML 95K
(Details)
79: R65 Acquisitions Smiths Medical 2020 Limited HTML 55K
Intangible (Details)
80: R66 Acquisitions Smiths Medical Pro Forma (Details) HTML 72K
81: R67 Acquisitions Foreign Infusion Systems Supplier HTML 53K
(Details)
82: R68 Restructuring, Strategic Transaction and HTML 45K
Integration (Details 1)
83: R69 Restructuring, Strategic Transaction and HTML 64K
Integration (Details 2)
84: R70 Restructuring, Strategic Transaction and HTML 40K
Integration Strategic Transaction and Integration
Expenses (Details)
85: R71 Revenue Disaggregation of Revenue - Product Line HTML 58K
(Details)
86: R72 Revenue Disaggregation of Revenue by Geography HTML 62K
(Details)
87: R73 Revenue Contract Liabilities (Details) HTML 57K
88: R74 Revenue Contract Liabilities Text (Details) HTML 40K
89: R75 Revenue Remaining Performance Obligation HTML 55K
Recognition Timing (Details)
90: R76 Leases (Details) HTML 46K
91: R77 Leases Lease Cost (Details) HTML 50K
92: R78 Leases Supplemental Cash Flow Lease Information HTML 50K
(Details)
93: R79 Leases Supplemental Balance Sheet Lease HTML 56K
information (Details)
94: R80 Finance Leases Supplemental Balance Sheet HTML 58K
Information (Details)
95: R81 Leases Lease Maturity (Details) HTML 58K
96: R82 Leases Finance Lease Maturity (Details) HTML 58K
97: R83 Share Based Award Stock Based Compensation HTML 49K
(Details)
98: R84 Share Based Award Stock Option Plans (Details) HTML 51K
99: R85 Share Based Award Stock Options Granted and HTML 66K
Valuation (Details)
100: R86 Share Based Award Stock Option Activity (Details) HTML 92K
101: R87 Share Based Award Share Award data (Details) HTML 40K
102: R88 Share Based Award Options exercised data (Details) HTML 45K
103: R89 Share Based Award RSU and PRSU (Details) HTML 67K
104: R90 Share Based Award RSU and PRSU Roll forward HTML 78K
(Details)
105: R91 Share Based Award ESPP Narrative (Details) HTML 41K
106: R92 Derivatives and Hedging Activities Foreign HTML 67K
Exchange Forward Contracts(Details)
107: R93 Derivatives and Hedging Activities Interest Rate HTML 65K
Contracts(Details)
108: R94 Derivatives and Hedging Activities Derivative HTML 86K
Balance Sheet Location (Details)
109: R95 Derivatives and Hedging Activities Derivative HTML 63K
Instruments and Hedging Activities - Amounts
Affecting Consolidated Statements of Income
(Details)
110: R96 Derivatives and Hedging Activities Derivative HTML 49K
Instruments and Hedging Activities - Cash Flow
Hedge Activity Included in Accumulated Other
Comprehensive Income (Loss) (Details)
111: R97 Fair Value Measurement Smiths Medical(Details) HTML 47K
112: R98 Fair Value Measurement Text Pursuit (Details) HTML 56K
113: R99 Fair Value Measurement Roll Forward (Details) HTML 66K
114: R100 Fair Value Measurement Smiths Medical Simulation HTML 46K
Inputs (Details)
115: R101 Fair Value Measurement Fair Value Measurements, HTML 120K
Recurring Basis (Details)
116: R102 Prepaid Expenses and Other Current Assets HTML 62K
(Details)
117: R103 Prepaids and Other Noncurrent Assets (Details) HTML 57K
118: R104 Accrued Liabilities (Details) HTML 86K
119: R105 Other Liabilities (Details) HTML 58K
120: R106 2022 Credit Facility Text (Details) HTML 92K
121: R107 2017 Credit Facility (Details) HTML 46K
122: R108 Applicable Margin Based on Leverage Ratio Term HTML 62K
Loan A(Details)
123: R109 Applicable Margin Based on Leverage Ratio Term HTML 47K
Loan B (Details)
124: R110 Debt (Details) HTML 68K
125: R111 Debt Maturity (Details) HTML 58K
126: R112 Debt Interest Expense (Details) HTML 50K
127: R113 Principal Payments (Details) HTML 40K
128: R114 Income Taxes Income (Loss) from Continuing HTML 46K
Operations (Details)
129: R115 Income Taxes Tax Provision (Details) HTML 65K
130: R116 Income Taxes Change in taxes payable (Details) HTML 40K
131: R117 Income Taxes Effective tax rate (Details) HTML 100K
132: R118 Income Taxes Deferred income tax assets HTML 78K
(Liabilities) (Details)
133: R119 Income Taxes Operating Loss Carryforwards HTML 46K
(Details)
134: R120 Income Taxes Tax Carryforwards (Details) HTML 45K
135: R121 Income Taxes Tax Holiday (Details) HTML 43K
136: R122 Income Taxes Undistributed foreign earnings HTML 41K
(Details)
137: R123 Income Taxes Unrecognized tax benefits (Details) HTML 55K
138: R124 Income Taxes Unrecognized tax benefits Text HTML 55K
(Details)
139: R125 Geographic Information and Significant Customers HTML 71K
Long Lived Assets by Geographic Location (Details)
140: R126 Stockholders' Equity (Details) HTML 48K
141: R127 Stockholders' Equity Accumulated Other HTML 69K
Comprehensive Income (Loss) (Details)
142: R128 Commitments and Contingencies Contingencies HTML 71K
(Details)
143: R129 Collaborative and Other Arrangements (Details) HTML 41K
144: R130 Transfers and Servicing (Details) HTML 50K
145: R131 SEC Schedule, Article 12-09, Valuation and HTML 68K
Qualifying Accounts (Details)
147: XML IDEA XML File -- Filing Summary XML 279K
150: XML XBRL Instance -- icui-20231231_htm XML 3.68M
146: EXCEL IDEA Workbook of Financial Report Info XLSX 207K
11: EX-101.CAL XBRL Calculations -- icui-20231231_cal XML 208K
12: EX-101.DEF XBRL Definitions -- icui-20231231_def XML 1.25M
13: EX-101.LAB XBRL Labels -- icui-20231231_lab XML 3.16M
14: EX-101.PRE XBRL Presentations -- icui-20231231_pre XML 1.90M
10: EX-101.SCH XBRL Schema -- icui-20231231 XSD 332K
148: JSON XBRL Instance as JSON Data -- MetaLinks 820± 1.15M
149: ZIP XBRL Zipped Folder -- 0000883984-24-000005-xbrl Zip 577K
 | Download this zipped .zip folder |
| Files: | exhibit103executiveofficer.htm exhibit104non-employeedire.htm exhibit21subsidiariesofreg.htm exhibit231consentofdeloitt.htm exhibit311123123.htm exhibit312123123.htm exhibit32123123.htm exhibit971clawbackpolicy.htm icui-20231231.htm icui-20231231.xsd icui-20231231_cal.xml icui-20231231_def.xml icui-20231231_g1.jpg icui-20231231_lab.xml icui-20231231_pre.xml |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/03/23 ICU Medical, Inc. 8-K:5,9 10/30/23 11:306K 5/22/23 ICU Medical, Inc. 8-K:5,9 5/17/23 11:225K 1/03/23 ICU Medical, Inc. 8-K:5,9 12/30/22 11:181K 4/20/22 ICU Medical, Inc. 8-K:5 4/15/22 11:332K 1/07/22 ICU Medical, Inc. 8-K:1,2,3,8 1/07/22 13:2.4M 9/08/21 ICU Medical, Inc. 8-K:1,7,8,9 9/08/21 15:6.7M Donnelley … Solutions/FA 3/02/20 ICU Medical, Inc. 10-K 12/31/19 141:15M 1/06/20 ICU Medical, Inc. 8-K:5,9 12/31/19 13:198K 5/10/19 ICU Medical, Inc. 10-Q 3/31/19 99:6.9M 5/10/18 ICU Medical, Inc. 10-Q 3/31/18 95:7.2M 1/06/17 ICU Medical, Inc. 8-K:5,9 1/06/17 2:170K 6/10/14 ICU Medical, Inc. 8-K:5,9 6/09/14 2:124K 4/03/13 ICU Medical, Inc. DEF 14A 5/10/13 1:1.4M 10/22/10 ICU Medical, Inc. 10-Q 9/30/10 31:2.4M Toppan Merrill/FA 4/03/02 ICU Medical, Inc. DEF 14A 5/16/02 1:134K Publicease Inc./FA |